Bristol-Myers Squibb (NYSE: BMY) Reaffirms Margin and Tax Targets, Raises FY25 Guidance
Bristol-Myers Squibb Company (NYSE: BMY)is a global biopharma leader dedicated to developing innovative treatments for serious diseases. Its pipeline spans therapeutic areas such as immunology, oncology, haematology, cardiovascular health, neuroscience, and more.
Team Kalkine |
05 Jul 2025| Read Time : 10 Mins